[{"NetIncomeLoss_1_Q1_USD":93000000.0,"InventoryRawMaterialsAndSupplies_0_Q1_USD":482000000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-167000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-329000000.0,"InterestPaidNet_1_Q1_USD":40000000.0,"PreferredStockValueOutstanding_0_Q1_USD":0.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":224000000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1_Q1_USD":-13000000.0,"OtherNonrecurringIncomeExpense_1_Q1_USD":9000000.0,"RepaymentsOfLongTermDebt_1_Q1_USD":3000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":91000000.0,"DepreciationAndAmortization_1_Q1_USD":81000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q1_USD":5000000.0,"InventoryGross_0_Q1_USD":685000000.0,"EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_0_Q1_USD":1000000.0,"PreferredStockSharesOutstanding_0_Q1_shares":384777.0,"DefinedBenefitPlanExpectedReturnOnPlanAssets_1_Q1_USD":2000000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-13000000.0,"AssetsCurrent_0_Q1_USD":3931000000.0,"RestructuringSettlementAndImpairmentProvisions_1_Q1_USD":1000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"DefinedBenefitPlanInterestCost_1_Q1_USD":1000000.0,"DividendsAndInterestPaid_1_Q1_USD":4000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-12000000.0,"Assets_0_Q1_USD":10183000000.0,"CommonStockSharesIssued_0_Q1_shares":171032640.0,"IncomeTaxesPaidNet_1_Q1_USD":15000000.0,"DeferredIncomeTaxLiabilities_0_Q1_USD":171000000.0,"ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_1_Q1_USD":9000000.0,"InventoryValuationReserves_0_Q1_USD":63000000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":359000000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":701000000.0,"ContractWithCustomerLiability_0_Q1_USD":299000000.0,"DerivativeGainLossOnDerivativeNet_1_Q1_USD":2000000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":183000000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q1_USD":-1000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":0.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":165000000.0,"PrepaidTaxes_0_Q1_USD":23000000.0,"InterestRateCashFlowHedgeAssetAtFairValue_0_Q1_USD":3000000.0,"DebtAndCapitalLeaseObligations_0_Q1_USD":4304000000.0,"InterestPayableCurrent_0_Q1_USD":11000000.0,"DefinedBenefitPlanNetPeriodicBenefitCost_1_Q1_USD":1000000.0,"Revenues_1_Q1_USD":1025000000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_1_Q1_USD":-5000000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":10000000.0,"AccountsReceivableNetCurrent_0_Q1_USD":831000000.0,"PaymentsToAcquireOtherInvestments_1_Q1_USD":4000000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":4000000.0,"PrepaidExpenseCurrent_0_Q1_USD":64000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":172000000.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":93000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":92000000.0,"EarningsPerShareBasic_1_Q1_USD":0.49,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":635000000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":6000000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q1_USD":4000000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_1_Q1_USD":1000000.0,"DepreciationExpenseOnReclassifiedAssets_1_Q1_USD":58000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":28000000.0,"Liabilities_0_Q1_USD":5803000000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":4234000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1969000000.0,"OtherAssetsNoncurrent_0_Q1_USD":277000000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":23000000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-6000000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":81000000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":84000000.0,"OtherAssetsCurrent_0_Q1_USD":53000000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":20000000.0,"ProceedsFromIssuanceOfDebt_1_Q1_USD":1096000000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q1_USD":8000000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1082000000.0,"ForeignCurrencyTransactionGainLossUnrealized_1_Q1_USD":-9000000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-9000000.0,"IncreaseDecreaseInInventories_1_Q1_USD":63000000.0,"ValueAddedTaxReceivable_0_Q1_USD":64000000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":70000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_1_Q1_USD":-26000000.0,"LiabilitiesCurrent_0_Q1_USD":1096000000.0,"OtherCostAndExpenseOperating_1_Q1_USD":4000000.0,"InventoryWorkInProcess_0_Q1_USD":203000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":171000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":163000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-14000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":21000000.0,"TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_1_Q1_USD":22000000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":4000000.0,"InterestIncomeExpenseNet_1_Q1_USD":-26000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":103000000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q1_USD":4225000000.0,"Goodwill_0_Q1_USD":2531000000.0,"TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax_1_Q1_USD":-28000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":1215000000.0,"DeferredRevenueCurrent_0_Q1_USD":283000000.0,"AccountsPayableCurrent_0_Q1_USD":363000000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":15000000.0,"DebtRelatedCommitmentFeesAndDebtIssuanceCosts_1_Q1_USD":4000000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2581000000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":4000000.0,"PreferredStockSharesIssued_0_Q1_shares":384777.0,"GainLossOnSalesOfAssetsAndAssetImpairmentCharges_1_Q1_USD":-3000000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":793000000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":4021000000.0,"IncreaseDecreaseInDeferredIncomeTaxes_1_Q1_USD":8000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":90000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":1000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":793000000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":25000000.0,"DefinedBenefitPlanAmortizationOfGainsLosses_1_Q1_USD":-1000000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":654000000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":8000000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":459000000.0,"NonoperatingIncomeExpense_1_Q1_USD":-9000000.0,"GrossProfit_1_Q1_USD":324000000.0,"AmortizationOfFinancingCosts_1_Q1_USD":2000000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":82000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":82000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":69000000.0,"DefinedBenefitPlanServiceCost_1_Q1_USD":1000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":21000000.0,"PreferredStockSharesAuthorized_0_Q1_shares":100000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":155000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":10183000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_1_Q1_USD":0.0,"ProfitLoss_1_Q1_USD":93000000.0,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1_Q1_USD":1000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q1_USD":-1000000.0,"InventoryNet_0_Q1_USD":622000000.0,"OtherNonoperatingExpense_1_Q1_USD":4000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_1_Q1_USD":-9000000.0,"OperatingIncomeLoss_1_Q1_USD":138000000.0,"CommonStockValueOutstanding_0_Q1_USD":2000000.0,"CommonStockSharesAuthorized_0_Q1_shares":1000000000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":1428000000.0,"DefinedBenefitPensionPlanLiabilitiesNoncurrent_0_Q1_USD":133000000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":178000000.0,"GoodwillAcquiredDuringPeriod_1_Q1_USD":25000000.0,"EarningsPerShareDiluted_1_Q1_USD":0.49,"CommonStockSharesOutstanding_0_Q1_shares":171032640.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_1_Q1_USD":-1000000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-185000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":1073000000.0,"DividendsPreferredStock_1_Q1_USD":4000000.0,"MarketableSecurities_0_Q1_USD":50000000.0,"OtherLiabilitiesCurrent_0_Q1_USD":164000000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":114000000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_1_Q1_USD":4000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":69000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":15000000.0,"ProceedsFromRepaymentsOfShortTermDebt_1_Q1_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":154000000.0,"DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_1_Q1_USD":-3000000.0,"StockholdersEquity_0_Q1_USD":4021000000.0,"DebtCurrent_0_Q1_USD":79000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":81000000.0,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2022.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20211102"}]